|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
49,450,000 |
Market
Cap: |
1.30(B) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$25.5 - $46.6 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : 623 |
Guru Rank Value : 3 |
Guru Occurances : 1 |
|
|
|
|
|
|
|
Company Profile Pacira BioSciences is a holding company. Through its subsidiaries, Co. is focused on non-opioid pain management. Co. has three commercialized non-opioid treatments: EXPAREL® (bupivacaine liposome injectable suspension), a long-acting, local analgesic approved for postsurgical pain management; ZILRETTA® (triamcinolone acetonide extended-release injectable suspension), an extended-release, intra-articular, corticosteroid injection indicated for the management of OA knee pain; and ioveradeg®, a handheld device for delivering immediate, long-acting, drug-free pain control using controlled doses of cold temperature to a targeted nerve.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
119,323 |
119,323 |
201,796 |
291,198 |
Total Sell Value |
$3,656,226 |
$3,656,226 |
$6,836,738 |
$12,122,941 |
Total People Sold |
1 |
1 |
15 |
17 |
Total Sell Transactions |
3 |
3 |
36 |
59 |
End Date |
2024-02-01 |
2023-10-31 |
2023-05-02 |
2022-05-02 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Winston Roy |
Chief Clinical Officer |
|
2020-11-13 |
4 |
AS |
$62.00 |
$310,000 |
D/D |
(5,000) |
34,785 |
|
13% |
|
Riker Lauren Bullaro |
Vice President, Finance |
|
2020-11-13 |
4 |
AS |
$63.81 |
$191,430 |
D/D |
(3,000) |
13,181 |
|
13% |
|
Riker Lauren Bullaro |
Vice President, Finance |
|
2020-11-13 |
4 |
OE |
$10.81 |
$32,430 |
D/D |
3,000 |
16,181 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2020-10-16 |
4 |
AS |
$55.56 |
$1,666,800 |
D/D |
(30,000) |
173,377 |
|
31% |
|
Stack David M |
CEO and Chairman |
|
2020-10-16 |
4 |
OE |
$10.81 |
$324,300 |
D/D |
30,000 |
203,377 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2020-10-15 |
4 |
AS |
$55.00 |
$1,650,000 |
D/D |
(30,000) |
173,377 |
|
28% |
|
Stack David M |
CEO and Chairman |
|
2020-10-15 |
4 |
OE |
$10.81 |
$324,300 |
D/D |
30,000 |
203,377 |
|
- |
|
Stack David M |
CEO and Chairman |
|
2020-10-14 |
4 |
AS |
$55.53 |
$1,665,900 |
D/D |
(30,000) |
173,377 |
|
36% |
|
Stack David M |
CEO and Chairman |
|
2020-10-14 |
4 |
OE |
$10.81 |
$324,300 |
D/D |
30,000 |
203,377 |
|
- |
|
Pace Gary W |
Director |
|
2020-09-25 |
4 |
OE |
$16.67 |
$1,166,900 |
D/D |
70,000 |
129,949 |
|
- |
|
Reinhardt Max |
President |
|
2020-09-17 |
4 |
AS |
$59.75 |
$1,520,318 |
D/D |
(25,420) |
14,000 |
|
10% |
|
Reinhardt Max |
President |
|
2020-09-17 |
4 |
OE |
$42.54 |
$1,063,500 |
D/D |
25,000 |
39,000 |
|
- |
|
Dunker Kristen Marie |
Chief Administrative Officer |
|
2020-09-17 |
4 |
AS |
$59.77 |
$1,667,290 |
D/D |
(27,871) |
24,887 |
|
10% |
|
Dunker Kristen Marie |
Chief Administrative Officer |
|
2020-09-17 |
4 |
OE |
$32.35 |
$1,092,268 |
D/D |
27,871 |
52,758 |
|
- |
|
Riker Lauren Bullaro |
Vice President, Finance |
|
2020-09-16 |
4 |
AS |
$60.34 |
$181,020 |
D/D |
(3,000) |
13,181 |
|
11% |
|
Riker Lauren Bullaro |
Vice President, Finance |
|
2020-09-16 |
4 |
OE |
$10.81 |
$32,430 |
D/D |
3,000 |
16,181 |
|
- |
|
Dunker Kristen Marie |
Chief Administrative Officer |
|
2020-09-16 |
4 |
AS |
$59.54 |
$1,675,150 |
D/D |
(27,853) |
24,887 |
|
11% |
|
Dunker Kristen Marie |
Chief Administrative Officer |
|
2020-09-16 |
4 |
OE |
$32.35 |
$1,091,560 |
D/D |
27,853 |
52,740 |
|
- |
|
Dunker Kristen Marie |
Chief Administrative Officer |
|
2020-09-15 |
4 |
AS |
$59.01 |
$1,654,058 |
D/D |
(27,853) |
24,887 |
|
16% |
|
Dunker Kristen Marie |
Chief Administrative Officer |
|
2020-09-15 |
4 |
OE |
$32.35 |
$1,091,560 |
D/D |
27,853 |
52,740 |
|
- |
|
Wicki Andreas |
Director |
|
2020-09-09 |
4 |
S |
$62.02 |
$137,436 |
I/I |
(2,216) |
692,970 |
|
-16% |
|
Stack David M |
CEO and Chairman |
|
2020-08-17 |
4 |
AS |
$61.79 |
$928,619 |
D/D |
(15,000) |
173,377 |
|
-5% |
|
Wicki Andreas |
Director |
|
2020-08-13 |
4 |
S |
$61.47 |
$2,145,549 |
I/I |
(34,904) |
695,186 |
|
2% |
|
Wicki Andreas |
Director |
|
2020-08-12 |
4 |
S |
$60.82 |
$6,903,070 |
I/I |
(113,500) |
730,090 |
|
4% |
|
Riker Lauren Bullaro |
Vice President, Finance |
|
2020-08-11 |
4 |
S |
$60.50 |
$494,890 |
D/D |
(8,180) |
13,181 |
|
2% |
|
781 Records found
|
|
Page 10 of 32 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|